OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Opicapone as an add-on to levodopa for reducing end-of-dose motor fluctuations in Parkinson’s disease: a systematic review and meta-analysis
Magdalena Żegleń, Katarzyna Śladowska, Paweł Kawalec, et al.
Journal of Comparative Effectiveness Research (2022) Vol. 11, Iss. 12, pp. 889-904
Closed Access | Times Cited: 5
Magdalena Żegleń, Katarzyna Śladowska, Paweł Kawalec, et al.
Journal of Comparative Effectiveness Research (2022) Vol. 11, Iss. 12, pp. 889-904
Closed Access | Times Cited: 5
Showing 5 citing articles:
Factors affecting continuation rates of opicapone: A retrospective study at a single center in Japan
Yuki Yasutaka, Takayasu Mishima, Kentaro Ogata, et al.
Clinical Neurology and Neurosurgery (2025) Vol. 252, pp. 108875-108875
Closed Access
Yuki Yasutaka, Takayasu Mishima, Kentaro Ogata, et al.
Clinical Neurology and Neurosurgery (2025) Vol. 252, pp. 108875-108875
Closed Access
Effectiveness and safety of different catechol-o-methyl transferase inhibitors for patients with parkinson’s disease: Systematic review and network meta-analysis
Wenshuo Wu, Xiaohui Lu, Liping Zhang, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 239, pp. 108189-108189
Closed Access | Times Cited: 3
Wenshuo Wu, Xiaohui Lu, Liping Zhang, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 239, pp. 108189-108189
Closed Access | Times Cited: 3
Clinical pharmacokinetics of levodopa and relevant add-on therapies for Parkinson’s disease
Thomas Müller
Expert Opinion on Drug Metabolism & Toxicology (2024), pp. 1-10
Closed Access | Times Cited: 2
Thomas Müller
Expert Opinion on Drug Metabolism & Toxicology (2024), pp. 1-10
Closed Access | Times Cited: 2
Adverse event profiles of adjuvant treatment with opicapone in Parkinson’s disease: A systematic review and meta-analysis
Luwen Xie, Xiaoyi Qi, Xuan Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Luwen Xie, Xiaoyi Qi, Xuan Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
Matilde Otero‐Losada, Paolo Gubellini, Francisco Capani, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access
Matilde Otero‐Losada, Paolo Gubellini, Francisco Capani, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access
